| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BEEM.2011.06.002 |
| P8608 | Fatcat ID | release_5lscabmb7fdstcf5pt2njef4fa |
| P932 | PMC publication ID | 3788574 |
| P698 | PubMed publication ID | 21925076 |
| P5875 | ResearchGate publication ID | 51649505 |
| P2093 | author name string | David N Herndon | |
| Celeste C Finnerty | |||
| Ludwik K Branski | |||
| Itoro E Elijah | |||
| P2860 | cites work | Insulin-like growth factor-I: a traffic control device on the road to tissue recovery | Q28205289 |
| Cutaneous wound healing | Q29618894 | ||
| The ghrelin axis in disease: potential therapeutic indications | Q30426399 | ||
| Increased mortality associated with growth hormone treatment in critically ill adults | Q33873359 | ||
| Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis | Q34026891 | ||
| Insulin-like growth factors I and II. | Q34221300 | ||
| Measurement of growth hormone, insulin-like growth factor I and their binding proteins: the clinical aspects | Q34428191 | ||
| Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms | Q34471690 | ||
| Treatment with growth hormone and insulin-like growth factor-I in critical illness | Q34500388 | ||
| Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin | Q34573364 | ||
| Neuroendocrine pathobiology of chronic critical illness | Q34761321 | ||
| Dynamic neuroendocrine responses to critical illness | Q34967278 | ||
| Mechanisms of action of GH. | Q35924654 | ||
| Hormone replacement treatment in Turner syndrome. | Q36461557 | ||
| Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness | Q36663946 | ||
| Insulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation. | Q36845604 | ||
| Is there a role for growth hormone therapy in refractory critical illness? | Q37211633 | ||
| A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung | Q37253992 | ||
| Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness | Q77312633 | ||
| Growth hormone treatment in pediatric burns: a safe therapeutic approach | Q77470222 | ||
| Dangers of growth hormone therapy in critically ill patients | Q77639818 | ||
| Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats | Q77753622 | ||
| Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats | Q77928320 | ||
| Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats | Q37344288 | ||
| Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children | Q37674052 | ||
| Genomic analysis of insulin-like growth factor-I gene transfer in thermally injured rats | Q38342413 | ||
| Actions of insulin-like growth factors | Q39494147 | ||
| The gut: a central organ after surgical stress | Q39538585 | ||
| Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role | Q39743558 | ||
| Growth factors and wound healing | Q40698941 | ||
| Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study | Q40984427 | ||
| Increased intestinal permeability associated with infection in burn patients | Q41390988 | ||
| Insulinlike growth factor 1 production is inhibited in human sepsis | Q41399625 | ||
| In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors | Q41626903 | ||
| Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin | Q42816906 | ||
| Insulinlike growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury | Q43874344 | ||
| Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. | Q43921879 | ||
| Endotoxin promotes the translocation of bacteria from the gut. | Q44213056 | ||
| The effect of perioperative exogenous growth hormone on wound bursting strength in normal and malnourished rats | Q44851643 | ||
| Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone | Q44942346 | ||
| IGF-I gene transfer in thermally injured rats | Q45861506 | ||
| Attenuation of the acute-phase response in thermally injured rats by cholesterol-containing cationic liposomes used as a delivery system for gene therapy | Q45862903 | ||
| Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound | Q45880076 | ||
| Overcoming the obstacles to gene therapy | Q45881952 | ||
| Nonviral strategies for gene therapy | Q45881959 | ||
| Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats | Q47320956 | ||
| Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3. | Q47982107 | ||
| Asphyxial brain injury--the role of the IGF system | Q48403241 | ||
| The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. | Q52059103 | ||
| Interaction of exogenous liposomal insulin-like growth factor-I cDNA gene transfer with growth factors on collagen expression in acute wounds. | Q53671140 | ||
| Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. | Q53859950 | ||
| Effects of recombinant human growth hormone in patients with severe sepsis | Q54256511 | ||
| Delirium in the intensive care unit. | Q55208111 | ||
| Growth Hormone Therapy in Short Children Born Small for Gestational Age | Q58811194 | ||
| Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis | Q67281730 | ||
| Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group | Q67554368 | ||
| Effects of recombinant human growth hormone on donor-site healing in severely burned children | Q68361548 | ||
| Multiple-organ-failure syndrome | Q68793720 | ||
| The effect of insulin-like growth factor I on postburn hypermetabolism | Q68879086 | ||
| Characterization of insulin-like growth factor-I/somatomedin-C receptors on human keratinocyte monolayers | Q70144476 | ||
| Use of growth hormone for postoperative respiratory failure | Q71181929 | ||
| Improvements in cationic liposomes for in vivo gene transfer | Q71732071 | ||
| Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial | Q72146888 | ||
| Optimizing liposome-mediated gene transfer in primary rat septo-hippocampal cell cultures | Q72153819 | ||
| Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury | Q72206680 | ||
| Clinical uses of insulin-like growth factor I | Q72264795 | ||
| Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients | Q72787238 | ||
| A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness | Q73351549 | ||
| Insulin-like growth factor-I liposomal gene transfer and systemic growth hormone stimulate wound healing | Q73597895 | ||
| Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response | Q73841517 | ||
| Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society | Q73853498 | ||
| Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy | Q73924203 | ||
| Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury | Q74065127 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 759-767 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Best Practice and Research: Clinical Endocrinology and Metabolism | Q15755890 |
| P1476 | title | The GH/IGF-1 system in critical illness | |
| P478 | volume | 25 |
| Q35778850 | A controlled, before-and-after trial of an urban sanitation intervention to reduce enteric infections in children: research protocol for the Maputo Sanitation (MapSan) study, Mozambique |
| Q39123579 | Biochemical investigations in diagnosis and follow up of acromegaly |
| Q42842551 | DNA demethylation enhances myoblasts hypertrophy during the late phase of myogenesis activating the IGF-I pathway |
| Q47734308 | Deterioration of Limb Muscle Function During Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
| Q35164062 | Effect of growth factors on antimicrobial peptides and pro-inflammatory mediators during wound healing |
| Q53186231 | Effect of growth factors on the migration of equine oral and limb fibroblasts using an in vitro scratch assay. |
| Q35035670 | Essential amino acid enriched high-protein enteral nutrition modulates insulin-like growth factor-1 system function in a rat model of trauma-hemorrhagic shock |
| Q48373900 | Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines |
| Q64964091 | Growth Hormone: Therapeutic Possibilities-An Overview. |
| Q104562985 | Growth hormone as a rescue treatment in maple syrup urine disease with lessons from pediatric burn literature, case report and brief literature review |
| Q36699521 | Hepatic growth hormone resistance after acute injury |
| Q33847474 | IGF-1 may predict the severity and outcome of patients with sepsis and be associated with microRNA-1 level changes |
| Q52653648 | Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver. |
| Q35743964 | Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure |
| Q36296818 | Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness |
| Q54977881 | Selective Insulin-like Growth Factor Resistance Associated with Heart Hemorrhages and Poor Prognosis in a Novel Preclinical Model of the Hematopoietic Acute Radiation Syndrome. |
| Q45208149 | Somatotropic and thyroid hormones in the acute phase of subarachnoid haemorrhage |
| Q40492427 | Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. |
| Q22305600 | Undernutrition in patients with COPD and its treatment |
| Q57822729 | Updates in Diagnosis and Treatment of Acromegaly |
Search more.